DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,034 filers reported holding DANAHER CORPORATION in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,009,879,814 | +17.0% | 4,070,455 | +13.2% | 0.27% | +20.4% |
| Q2 2023 | $863,222,808 | -4.1% | 3,596,762 | +0.7% | 0.23% | -10.0% |
| Q1 2023 | $899,885,633 | -18.2% | 3,570,408 | -13.9% | 0.25% | -22.0% |
| Q4 2022 | $1,100,510,679 | +10.2% | 4,146,299 | +7.2% | 0.32% | +0.3% |
| Q3 2022 | $998,583,000 | +18.6% | 3,866,145 | +16.5% | 0.32% | +25.9% |
| Q2 2022 | $841,628,000 | -17.3% | 3,319,762 | -4.3% | 0.26% | -1.9% |
| Q1 2022 | $1,017,810,000 | -6.0% | 3,469,851 | +5.5% | 0.26% | -0.4% |
| Q4 2021 | $1,082,297,000 | +15.7% | 3,289,555 | +7.1% | 0.26% | +10.1% |
| Q3 2021 | $935,089,000 | +17.4% | 3,071,502 | +3.5% | 0.24% | +20.9% |
| Q2 2021 | $796,527,000 | +15.8% | 2,968,131 | -2.8% | 0.20% | +6.5% |
| Q1 2021 | $687,609,000 | +7.0% | 3,054,954 | +5.6% | 0.18% | -1.6% |
| Q4 2020 | $642,356,000 | +8.7% | 2,891,674 | +5.4% | 0.19% | -6.5% |
| Q3 2020 | $590,956,000 | +23.6% | 2,744,422 | +1.5% | 0.20% | +17.0% |
| Q2 2020 | $477,938,000 | +70.2% | 2,702,815 | +33.2% | 0.17% | +44.9% |
| Q1 2020 | $280,848,000 | -4.8% | 2,029,103 | +5.6% | 0.12% | +28.3% |
| Q4 2019 | $295,001,000 | +9.6% | 1,922,077 | +3.2% | 0.09% | +31.4% |
| Q3 2019 | $269,115,000 | +1.9% | 1,863,285 | +0.9% | 0.07% | +2.9% |
| Q2 2019 | $264,031,000 | -25.0% | 1,847,411 | -30.7% | 0.07% | -42.9% |
| Q1 2019 | $352,103,000 | +23.6% | 2,667,036 | -3.5% | 0.12% | +9.2% |
| Q4 2018 | $284,905,000 | -7.9% | 2,762,866 | -3.0% | 0.11% | +12.4% |
| Q3 2018 | $309,357,000 | +13.4% | 2,847,019 | +3.0% | 0.10% | +7.8% |
| Q2 2018 | $272,689,000 | +32.3% | 2,763,359 | +31.3% | 0.09% | +16.9% |
| Q1 2018 | $206,084,000 | -1.0% | 2,104,838 | -6.1% | 0.08% | +2.7% |
| Q4 2017 | $208,169,000 | -1.2% | 2,242,727 | -8.7% | 0.08% | -3.8% |
| Q3 2017 | $210,620,000 | +0.4% | 2,455,352 | -1.2% | 0.08% | +20.0% |
| Q2 2017 | $209,690,000 | +1.0% | 2,484,774 | +2.3% | 0.06% | -4.4% |
| Q1 2017 | $207,714,000 | +10.7% | 2,428,553 | +0.8% | 0.07% | +7.9% |
| Q4 2016 | $187,601,000 | -1.9% | 2,410,096 | -1.2% | 0.06% | -4.5% |
| Q3 2016 | $191,224,000 | -25.1% | 2,439,404 | -3.5% | 0.07% | -29.8% |
| Q2 2016 | $255,314,000 | +11.3% | 2,527,866 | +4.5% | 0.09% | +1.1% |
| Q1 2016 | $229,429,000 | +3.6% | 2,418,607 | +1.5% | 0.09% | +5.7% |
| Q4 2015 | $221,371,000 | -0.8% | 2,383,411 | -9.0% | 0.09% | -7.4% |
| Q3 2015 | $223,087,000 | -2.1% | 2,618,095 | -1.7% | 0.10% | +6.7% |
| Q2 2015 | $227,843,000 | +4.6% | 2,662,027 | +3.7% | 0.09% | +6.0% |
| Q1 2015 | $217,913,000 | +129.3% | 2,566,702 | +131.5% | 0.08% | +127.0% |
| Q4 2014 | $95,025,000 | +102.9% | 1,108,696 | +79.9% | 0.04% | +94.7% |
| Q3 2014 | $46,832,000 | -44.6% | 616,370 | -42.6% | 0.02% | -42.4% |
| Q2 2014 | $84,525,000 | +9.1% | 1,073,604 | +4.0% | 0.03% | +6.5% |
| Q1 2014 | $77,461,000 | -61.4% | 1,032,803 | -60.3% | 0.03% | -61.2% |
| Q4 2013 | $200,765,000 | +2.9% | 2,600,581 | -7.6% | 0.08% | -5.9% |
| Q3 2013 | $195,161,000 | -14.3% | 2,815,371 | -21.7% | 0.08% | -19.8% |
| Q2 2013 | $227,603,000 | – | 3,595,618 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |